Thursday, May 14, 2015

Top Japanese Companies To Invest In Right Now

Top Japanese Companies To Invest In Right Now: Cellular Dynamics International Inc (ICEL)

Cellular Dynamics International, Inc., incorporated on November 16, 2007, develops and manufactures fully functioning human cells in industrial quantities to precise specifications. The Companys iCell Operating System (iCell O/S) includes true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). Customers use its iCell O/S products, among other purposes, for drug discovery and screening; to test the safety and efficacy of their small molecule and biologic drug candidates; for stem cell banking; and in researching cellular therapeutics. The Companys iCell product line includes four different cell types: cardiomyocytes, neurons, hepatocytes and endothelial cells. The Company is actively developing an additional seven different cell types. iCell products are a consumable designed to be used once and then reordered.

The Company manufactures its iCell products from its iPSCs. An iPSC is a cell that has the ability both to replicate indefinitely and to be transformed into any cell type in the human body. The Companys iCell O/S consists of six products, which include iCell Cardiomyocytes, iCell Neurons, iCell Endothelial Cells, iCell Hepatocytes and MyCell.

Advisors' Opinion:
  • [By John Udovich]

    Stem cells may not be in the news muchas the sector has moved beyond the use of embryoticones, but small cap stem cell stocks Cellular Dynamics International Inc (NASDAQ: ICEL), International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX) have been fairly active over the past several trading days as ICEL went public, ISCO raised additional funding and BRTX grabbed more attention:

  • source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-japanese-companies-to-invest-in-rig! ht-now.html

Wednesday, May 13, 2015

10 Best US Stocks To Own Right Now

Futures trading was mixed ahead of Cyber Monday, the busiest online shopping day of the year.

In pre-market trading Monday, the Dow Jones industrial average index was up 0.1%, while the Nasdaq composite index was up 0.1% and the Standard & Poor's 500 index fell 0.04%.

On Friday, stocks closed mixed during a shortened holiday session. The Dow Jones industrial average and Standard & Poor's 500 each lost 0.1%. But the Nasdaq composite continued its winning ways, climbing 0.4%.

FRIDAY: Stocks mixed as investors eye Black Friday sales

RETAIL: Black Friday and holiday shopping brighter than forecast

In Asia, Shanghai's Composite Index fell 0.6% to 2,207.37 after two reports showed little growth in Chinese manufacturing. Hong Kong's Hang Seng idex climbed 0.7% to 24,038.55. Japan's Nikkei 225 dropped 0.04% to close at 15,655.07.

Top Solar Stocks To Own For 2016: Sandstorm Gold Ltd (SAND)

Sandstorm Gold Ltd. (Sandstorm Gold), formerly Sandstorm Resources Ltd., is a gold streaming company. The Company provides financing to gold mining companies that are looking for capital and in return, receives a gold streaming agreement. It is a non-operating gold mining company with seven gold streams in the portfolio, five of which are producing gold. The Company�� projects include the Aurizona Gold project, the Santa Elena project, the Summit Mine project, the Ming Mine project, the Black Fox Mine project, Bracemac-McLeod project and the Bachelor Lake Mine. It holds 17% interest in the mine gold production from Aurizona. Santa Elena Project, in which the Company holds 20% interest. It holds 12% interest in the mine gold production from Black fox mine project. The Summit Mine project, in which it has 50% interest, 25% interest in Ming mine project and 17.5% interest in Bracemac-McLeod project. Advisors' Opinion:
  • [By The Investment Doctor]

    Another, less likely possibility to raise equity is through selling a part of the precious metals in a streaming deal. I can imagine Sandstorm Gold (SAND) and Silver Wheaton (SLW) would be very interested in a substantial precious metals streaming agreement. At the current gold and silver prices NGEX wouldn't even have to sell its entire precious metals production under a streaming arrangement.

  • [By Tony Daltorio]

    The chief executive officers (CEOs) of both Silver Wheaton (NYSE: SLW) and Sandstorm Gold (NYSE MKT: SAND) told the Forum now was a great time to bolster their gold streams at a nice discount in price.

  • [By Rich Duprey]

    Still a glittering opportunity?
    While virtually every name in the precious metal fell yesterday in line with gold's percentage drop, or worse, gold streamer Sandstorm Gold (NYSEMKT: SAND  ) really took it on the chin, falling more than 8% despite reporting a few days earlier a sharp jump in proven and probable reserves at its Aurizona Gold Mine in Brazil. It represents one of the streamer's best opportunities for the future, as it has the opportunity to buy 17% of the gold produced for the life of mine at $400 an ounce on an inflation-adjusted basis.

10 Best US Stocks To Own Right Now: V.F. Corporation(VFC)

V.F. Corporation designs and manufactures, or sources from independent contractors various apparel and footwear products primarily in the United States and Europe. The company offers apparel, footwear, outdoor gear, skateboard-inspired and surf-inspired footwear, backpacks, luggage, handbags and accessories, outdoor apparel, travel accessories, and women?s active wear primarily under the Vans, The North Face, JanSport, Eastpak, Kipling, Napapijri, Reef, Eagle Creek, and lucy brands; and denim and casual bottoms, and tops principally under Wrangler, Lee, Riders, Rustler, and Timber Creek by Wrangler brands. Its products also include occupational, athletic, and licensed apparel primarily under the Red Kap, Bulwark, Majestic, MLB, NFL, and Harley-Davidson brands; men?s fashion sportswear, denim bottoms, sleepwear, underwear, as well as handbags, luggage, backpacks, and accessories principally under the Nautica and Kipling brands; and denim and casual bottoms, sportswear, acce ssories, men?s apparel and footwear, and women?s sportswear primarily under the 7 For All Mankind, John Varvatos, Splendid, and Ella Moss brands. The company sells its products to specialty stores, department stores, national chains, and mass merchants primarily through its sales force, independent sales agents, and distributors. V.F. Corporation was founded in 1899 and is based in Greensboro, North Carolina.

Advisors' Opinion:
  • [By Sara Murphy]

    VF (NYSE: VFC  ) , owner of such brands as The North Face and Lee, acknowledged that the 2010 "once-in-a-century" floods in Pakistan and Australia, coupled with wet weather and freezes, "ravaged cotton crops resulting in drastic increases in the price of cotton," which had "a material effect on our business as we sought a balance between absorbing the cost and raising prices on our cotton goods."

  • [By Ben Levisohn]

    Shares of Ralph Lauren have gained 5.2% to $180.07 at 3:33 p.m. today, and they’ve even boosted other apparel companies. PVH (PVH) has gained 0.7% to $125.75, Hanesbrands (HBI) has advanced 1.3% to $68.25 and VF Corp. (VFC) is up 0.9% to $2221.78.

10 Best US Stocks To Own Right Now: Euro/Forint(GY)

GenCorp Inc. engages in the manufacture and sale of aerospace and defense products and systems in the United States. The company operates in two segments, Aerospace and Defense, and Real Estate. The Aerospace and Defense segment offers defense system products, including liquid, solid, and air-breathing propulsion systems and components for applications in missile defense systems, maneuvering propulsion systems, precision war-fighting systems, and specialty metal products, as well as for use in strategic, tactical, and precision strike missiles. This segment also provides composite and metallic aerospace structural components, and warhead and armament systems for precision tactical and long range weapon applications. In addition, it provides liquid, solid, and electric propulsion systems and components for space systems, such as expendable and reusable launch vehicles, transatmospheric vehicles, manned and unmanned spacecraft, separation and maneuvering systems, upper stage engines, satellites, solid boosters, and integrated propulsion subsystems. This segment serves military, civil, and commercial space customers; Department of Defense; National Aeronautics and Space Administration; aerospace, defense, and commercial prime contractors; and various agencies of the United States government. The Real Estate segment engages in the re-zoning, entitlement, sale, and leasing of the company?s excess real estate assets; and owns approximately 12,200 acres of land in the Sacramento metropolitan area. GenCorp Inc. was founded in 1915 and is headquartered in Rancho Cordova, California.

Advisors' Opinion:
  • [By Rich Smith]

    On Monday, the GenCorp (NYSE: GY  ) subsidiary announced that it has won a contract from the U.S. Air Force Nuclear Weapons Center Propulsion Applications Program to demonstrate a new Medium Class Stage III motor that could be used to refurbish America's aging arsenal of Minuteman III Intercontinental Ballistic Missiles.

  • [By Rich Smith]

    GenCorp (NYSE: GY  ) probably also comes to mind. It's hard to imagine a company with more of a 1950s space-frontier feel to it than the one that owns Rocketdyne -- a name that could have come straight out of a pulp Heinlein novel.

  • [By Jake L'Ecuyer]

    Equities Trading DOWN
    Shares of GenCorp (NYSE: GY) were down 3.97 percent to $17.86 after the company reported Q1 results. GenCorp reported a Q1 loss of $0.03 per share.

10 Best US Stocks To Own Right Now: Vanguard Intermediate Term Bond ETF (BIV)

Vanguard Intermediate-Term Bond ETF (the Fund) seeks to track the performance of a market-weighted bond index with an intermediate-term, dollar-weighted average maturity. The Fund employs a passive management or indexing strategy designed to track the performance of the Barclays Capital U.S. 5-10 Year Government/Credit Bond Index (the Index). The Index includes all medium and larger issues of the United States Government, investment-grade corporate, and investment-grade international dollar-denominated bonds that have maturities between 5 and 10 years and are publicly issued. The Fund invests by sampling the Index, meaning that it holds a range of securities that, in the aggregate, approximate the full Index in terms of key risk factors and other characteristics. All of the Fund�� investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the Index. The Fund�� investment advisor is The Vanguard Group, Inc. Advisors' Opinion:
  • [By GURUFOCUS]

    In addition to individual stocks several funds pay a monthly dividend. Below is a sampling of these:
    Monthly Bond Funds- iShares Barclays 1-3 Year Credit Bond (CSJ) | Yield: 1.29%
    - Vanguard Short-Term Bond ETF (BSV) | Yield: 1.25%
    - Vanguard Intermediate-Term Bond ETF (BIV) | Yield: 2.96%
    - Vanguard Long-Term Bond ETF (BLV) | Yield: 4.42%

10 Best US Stocks To Own Right Now: Select Sector Utilities Select Sector SPDR Fund (XLU)

Select Sector Utilities Select Sector SPDR Fund (the Fund), formerly Utilities Select Sector SPDR Fund, seeks to provide investment results that correspond to the price and yield performance of the Utilities Select Sector of the S&P 500 Index (the Index). The Index includes companies that produce, generate, transmit or distribute electricity or natural gas.

The Fund utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. The Fund�� investment advisor is SSgA Funds Management, Inc.

Advisors' Opinion:
  • [By Matthew McCall]

    The SPDR Utilities ETF (NYSE: XLU) is up 1.5 percent today and is breaking to a one-month high. The iShares Cohen & Steers Realty ETF (NYSE: ICF), which owns a basket of REITs, is up 1.1 percent, also looking for a one-month high.

10 Best US Stocks To Own Right Now: Lockheed Martin Corporation(LMT)

Lockheed Martin Corporation engages in the research, design, development, manufacture, integration, operation, and sustainment of advanced technology systems and products in the areas of defense, space, intelligence, homeland security, and government information technology in the United States and internationally. It also provides management, engineering, technical, scientific, logistic, and information services. The company operates in four segments: Aeronautics, Electronic Systems, Information Systems & Global Services (IS&GS), and Space Systems. The Aeronautics segment offers military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. Its products and programs comprise the F-35 multi-role, stealth fighter; the F-22 air dominance and multi-mission stealth fighter; the F-16 multi-role fighter; the C-130J tactical transport aircraft; and the C-5M strategic airlifter modernization program; and support for the P-3 maritime patrol aircraft, and the U-2 high-altitude reconnaissance aircraft. The Electronic Systems segment provides air and missile defense; tactical missiles; weapon fire control systems; surface ship and submarine combat systems; anti-submarine and undersea warfare systems; land, sea-based, and airborne radars; surveillance and reconnaissance systems; simulation and training systems; and integrated logistics and sustainment services. The IS&GS segment offers information technology solutions and advanced technology primarily in the areas of software and systems integration for space, air, and ground systems to various defense and civil government agencies. The Space Systems segment provides government and commercial satellites; strategic and defensive missile systems, including missile defense technologies and systems, and fleet ballistic missiles; and space transportation systems. Lockheed Martin Corporation was founded in 1909 and is based in Bethesda, Maryland.

Advisors' Opinion:
  • [By Rich Smith]

    Only five privately held firms will participate in this two-year contract (extendable up to five years). No publicly traded firms at all were chosen to participate -- but publicly traded firms did still win a few of the day's smaller contracts, among them:

    A $76.1 million contract modification awarded to the Bell-Boeing Joint Project Office, a joint venture between Textron� (NYSE: TXT  ) and Boeing (NYSE: BA  ) , which instructs the JPO to delivery one single additional CV-22 tiltrotor aircraft to the U.S. Air Force by December 2016. A $39.4 million fixed-price with economic-price-adjustment contract for Sysco (NYSE: SYY  ) to provide "prime vendor food and beverage support" to the U.S. Army, Navy, Air Force, and Job Corps in Florida through April 16, 2019. A $32.3 million option exercise for NuStar Energy L.P. (NYSE: NS  ) subsidiary Shore Terminals LLC to provide "petroleum storage services" to the U.S. Army, Air Force, and Marine Corps through Nov. 30, 2016. A $7.7 million undefinitized contract modification compensating Lockheed Martin (NYSE: LMT  ) for "non-recurring sustainment activities" performed on behalf of the government of the United Kingdom, related to the latter's purchase of F-35 Lightning II stealth fighter jets. This contract has a completion date of June 201
  • [By Dividends4Life]

    Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1. Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number CINF is trading at a discount to only 3.) above. The stock is trading at a 36.8% premium to its calculated fair value of $34.96. CINF did not earn any Stars in this section. Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description: 1. Free Cash Flow Payout 2. Debt To Total Capital 3. Key Metrics 4. Dividend Growth Rate 5. Years of Div. Growth 6. Rolling 4-yr Div. > 15% CINF earned two Stars in this section for 1.) and 2.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. The company has paid a cash dividend to shareholders every year since 1954 and has increased its dividend payments for 54 consecutive years. Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1. NPV MMA Diff. 2. Years to > MMA The NPV MMA Diff. of the $62 is below the $500 target I look for in a stock that has increased dividends as long as CINF has. If CINF grows its dividend at 1.2% per year, it will take 5 years to equal a MMA yielding an estimated 20-year average rate of 3.68%. Memberships and Peers: CINF is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Divid

  • [By Rich Smith]

    And don't forget about the allies
    Foreign buyers of U.S. military equipment were behind a number of contracts awarded last week. Among them:

    Honeywell (NYSE: HON  ) won one of the week's biggest contracts to support the militaries of U.S. allies Australia, Morocco, Turkey, and the United Arab Emirates. Honeywell will be shipping out to these countries a total of 440 T55-GA-714A engines and 365 T55-GA-714A engine fielding kits. Among other aircraft, the T55-GA-714A engine is used to power CH-47 Chinook transport helicopters, an aircraft that is present in (or, in the case of Turkey, on order by) the militaries of all four countries. The total value of this contract modification to Honeywell will be nearly $122 million. Lockheed Martin (NYSE: LMT  ) won a $50 million contract to supply the militaries of South Korea and Finland with M934E6 and M934E7 warhead fuses for use with these countries' arsenals of Stinger shoulder-fired anti-aircraft missiles (often called "MANPADS," short for man-portable air defense systems). Deliveries of the fuses will continue through Aug. 25, 2018. Textron's (NYSE: TXT  ) Cessna unit won a $64 million contract to provide "support" and training services to Afghan pilots and mechanics servicing 26 C-208B "Caravan" and six T-182T "Skylane" utility aircraft through based at Kabul International Airport, Kandahar Air Base, and Shindand Air Base in Afghanistan through Jan. 31, 2016.

    Opportunities on the horizon
    So much for the contracts everyone knows about. Now, let's end last week's roundup with one contract that you may not yet have heard of.

  • [By Rich Smith]

    As the week wound down, Lockheed Martin (NYSE: LMT  ) claimed a pair of contract wins from the Pentagon, worth more than $17.1 million combined.

10 Best US Stocks To Own Right Now: Bed Bath & Beyond Inc.(BBBY)

Bed Bath & Beyond Inc., together with its subsidiaries, operates a chain of retail stores. It sells a range of domestic merchandise, such as bed linens and related items, bath items, and kitchen textiles; and home furnishings, including kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and certain juvenile products. The company also offers giftware, household products, and health and beauty care items; and infant and toddler merchandise. It operates stores under the names of Bed Bath & Beyond (BBB), Christmas Tree Shops (CTS), Harmon and Harmon Face Values (Harmon), and buybuy BABY. As of August 27, 2011, the company had a total of 1,155 stores, including 986 BBB stores, 70 CTS stores, 54 buybuy BABY stores, and 45 Harmon stores in 50 states, the District of Columbia, Puerto Rico, and Canada. It also operates two stores under the name of Home & More in the Mexico City through a joint venture. Bed Bath & Beyond Inc. was foun ded in 1971 and is based in Union, New Jersey.

Advisors' Opinion:
  • [By Ben Levisohn]

    Not that the market wasn’t without its losers. Bed Bath & Beyond�(BBBY) fell after it lowered its earnings forecasts, while JC Penney (JCP) dropped 16% after releasing a statement that praised its holiday sales but offered no numbers to back it up.

  • [By Teresa Rivas]

    On Thursday, Bed, Bath & Beyond (BBBY) after its earnings forecast disappointed. Citigroup�� Kate McShane also downgraded the stock from Buy to Neutral on the news, lowering her target price from $85 to $72.

    McShane writes that excluding the effect of her conservative assumptions for share repurchases, earnings per share growth looks to be virtually flattish for the next two years. The announcement Thursday night indicates that ��he company is facing a 2nd straight year of top-line deceleration driven by both slowing new store openings and modest comp growth.��Moreover, she writes, she doesn�� see an inflection point for gross margin in the next year, as she had previously thought possible, and she is concerned about the ��ngoing increasing negative impact from couponing.��/p>

    She notes that while investments in technology may improve Bed, Bath�� omni-channel experience, this strategy will continue to weigh on EPS, and she now likes Williams Sonoma (WSM) as a better way to get exposure to favorable trends in home furnishings.

    Her new estimates:

    Lowering our FY15 EPS from $5.36 to $5.04 ��e are taking down our EPS estimates on a slower comp environment over the next few years which will make it more difficult to leverage expenses, especially in light of continued investments in the omni-channel experience. Plus, the mix shift toward lower margin products may persist and the couponing reliance appears to be a permanent overhang. Lastly, the square footage expansion story for FY15 was less than we had expected and the opportunity to get a sales lift from square footage growth may be waning.

     

  • [By Rick Munarriz]

    In this video, longtime Fool contributor Rick Munarriz explains why Bed Bath & Beyond (NASDAQ: BBBY  ) and Costco (NASDAQ: COST  ) are holding up well at a time when Barnes & Noble (NYSE: BKS  ) and Best Buy (NYSE: BBY  ) are turning to dramatic makeovers to remain relevant.

  • [By Ben Levisohn]

    JC Penney’s (JCP) stock has been undergoing something of a renaissance during the past month. Bed Bath & Beyond’s (BBBY) has been standing still. Could the two be related?

Tuesday, May 12, 2015

5 Best Diversified Bank Stocks To Watch Right Now

Citigroup Inc (NYSE:C) will issue its first quarter results via press release at approximately 8 a.m. (ET) on Monday, April 14, 2014. At 11 a.m. (ET), results will be reviewed via live webcast and teleconference.

Wall Street anticipates that money center will earn $1.14 per share for the quarter, which is $0.09 less than last year's profit of $1.23 per share. iStock expects C �to miss Wall Street's consensus number. The iEstimate is $1.13, a penny less than expected.

Sales, like earnings, are expected to slip, dropping 5.5% year-over-year (YoY). Citigroup's consensus revenue estimate for Q1 is $19.37 billion, lower than last year's $20.49 billion.

[Related -JPMorgan Chase & Co. (JPM) Q1 Earnings Preview: Regulation Costs To Trim Guidance?]

Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.

Hot Safest Companies To Own For 2016: EQT Midstream Partners LP (EQM)

EQT Midstream Partners, LP owns, operates, acquires and develops midstream assets in the Appalachian Basin. The Company provides substantially all of its natural gas transmission, storage and gathering services under contracts with fixed reservation and/or usage fees. The Company focuses its operations in the Marcellus Shale fairway in southern Pennsylvania and northern West Virginia. It provides midstream services to EQT Corporation in the Appalachian Basin across 22 counties in Pennsylvania and West Virginia through its two primary assets: its transmission and storage system, which serves as a header system transmission pipeline, and its gathering system, which delivers natural gas from wells and other receipt points to transmission pipelines.

Equitrans Transmission and Storage System

As of December 31, 2011, the Company�� transmission and storage system included an approximately 700 mile FERC-regulated interstate pipeline system that connects to five interstate pipelines and multiple distribution companies, and it is supported by 14 associated natural gas storage reservoirs with approximately 400 million cubic feet per day of peak withdrawal capability and 32 billion cubic feet of working gas capacity. As of December 31, 2011, its transmission assets had total throughput capacity of approximately 1.0 trillion British thermal units per day.

Equitrans Gathering System

The Company�� gathering system consists of approximately 2,100 miles of FERC-regulated low-pressure gathering lines that have multiple delivery interconnects with its transmission and storage system and a gathering and interstate pipeline system owned and operated by Dominion Transmission, Inc.

Advisors' Opinion:
  • [By Lee Jackson]

    EQT Midstream Partners L.P. (NYSE: EQM) has everything the Oppenheimer team is looking for: low-risk, fee-based contracts in an attractive region, low financial leverage, high distribution growth and coverage and a supportive parent with assets to sell. Oppenheimer has a $55 price target for the stock. The Thomson/First Call estimate is at $54. Investors are paid a 3.4% distribution which Oppenheimer thinks may grow to 4.3% in 2014. Remember, MLP distributions may include return of principal.

  • [By Robert Rapier]

    Rounding out the top five were�Hi-Crush Partners�(NYSE: HCLP), another supplier of fracking sand (+71 percent),�EQT Midstream Partners�(NYSE: EQM), a midstream provider in the Appalachian Basin (+66.5 percent), and�Valero Energy Partners�(NYSE:VLP) (+61.5 percent), which consists of midstream assets dropped down from the refiner�Valero Energy�(NYSE:VLO).

  • [By Michael Flannelly]

    Goldman Sachs analysts started coverage on EQT Midstream Partners LP (EQM) early on Monday, giving the oil and natural gas distribution company a bullish rating due to its low-risk cash flows.

    The analysts rate EQM as “Buy” and see shares reaching $59. This price target suggests a 22% upside to the stock’s Friday closing price of $48.28.

    Goldman Sachs analyst Theodore Durbin said, “EQM’s FERCregulated pipeline and storage assets offer stable, low-risk fee-based cash flows supported by firm long-term contracts. A robust production outlook in the Marcellus and meaningful inventory of dropdown assets at the parent enhances distribution growth visibility. EQM has a low cost of capital, no debt outstanding, high liquidity and an aligned sponsor that should bolster the partnership�� multi-year double-digit distribution growth outlook.”

    EQT Midstream Partners shares were inactive during pre-market trading on Monday. The stock is up 54.99% year-to-date.

  • [By Matt DiLallo]

    Unfortunately for XTO Energy, there was one small and, unbeknownst to anyone, unresolved matter. You see, LINN had a contract to sell its gas through a unit of Dominion Resources (NYSE: D  ) , which was gathering the gas in its system. However, LINN's gas wasn't up to the system's standards, so it began to look for another gatherer and it approached Equitrans, which is now part of EQT Midstream Partners (NYSE: EQM  ) but formerly was a unit of EQT Corp. (NYSE: EQT  ) -- they talked, but nothing was signed. However, an EQT employee later that year thought that it had and began crediting gas to the wrong company.

5 Best Diversified Bank Stocks To Watch Right Now: Dex Media Inc (DXM)

Dex Media, Inc., incorporated on August 17, 2012, is a provider of social, local and mobile marketing solutions for local businesses. The Company provides marketing solutions that include Websites, print, mobile, search engine and social media solutions. The Company�� brands include Dex One and SuperMedia. Through both brands, it delivers a range of social, mobile, and print solutions.

The Company's consumer services include the Dex Knows.com and Superpages.com online and mobile search portals and applications and local print directories. On April 30, 2013, Dex One Corporation and SuperMedia Inc. announced the completion of their merger, creating Dex Media, Inc.

Advisors' Opinion:
  • [By Roberto Pedone]

    Dex Media (DXM) is a provider of marketing solutions that include Web sites, print, mobile, search engine and social media solutions for local businesses, through its Dex One and SuperMedia Marketing Consultants. This stock closed up 5.6% at $10.25 in Thursday's trading session.

    Thursday's Volume: 471,000

    Three-Month Average Volume: 280,277

    Volume % Change: 105%

    From a technical perspective, DXM spiked sharply higher here right above some near-term support at $9 with above-average volume. This stock has been downtrending badly for the last four months, with shares plunging lower from its low of $23.86 to its recent low of $8.85. During that move, shares of DXM have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of DXM have started to see its downside volatility stop as the stock has rebound off oversold levels. This stock got so oversold that its relative strength index reading recently dipped below 20. Shares of DXM are now starting to move within range of triggering a big breakout trade. That trade will hit if DXM manages to take out its 200-day moving average at $11.61 with high volume.

    Traders should now look for long-biased trades in DXM as long as it's trending above some key near-term support levels at $9 or $8.85 and then once it sustains a move or close above Thursday's high at $10.51 and its 200-day at $11.61 with volume that's near or above 280,277 shares. If that breakout hits soon, then DXM will set up to re-test or possibly take out its 50-day moving average of $13.72.

  • [By Ben Levisohn]

    Since the last conference, for every winning pick like Akamai Technolgies (AKAM)–which gained 19% after being picked by Blue Harbour Group’s Clifton Robbins–or Digital Realty Trust (DLR)–which rose fell 27.5% after being picked as a short by Jonathon Jacobson of Highfields Capital Management–there’s been a stinker like Chipotle Mexican Grill�(CMG)–which gained 29% after Double Line’s Jeffrey Gundlach recommended shorting it–or Dex Media (DXM)–which advanced 53.7% after Hayman Capital’s Kyle Bass recommended selling. In fact, the average pick lost 3.8%, even as the S&P 500 gained 15.2%.

5 Best Diversified Bank Stocks To Watch Right Now: Open Text Corporation (OTEX)

Open Text Corporation develops, markets, sells, licenses, and supports enterprise content management (ECM) solutions primarily in North America and Europe. The company?s ECM software and solutions enable customers to manage various types of enterprise content, including business documents, Web content, records, digital assets, email, forms and reports, forums, blogs, wikis, and real time instant messaging and collaboration. Its ECM solutions comprise various components, including document management, which provides repository for business documents, such as Microsoft office, CAD, and PDF; collaboration that offers tools designed to better facilitate people working with each other with content and processes; Web content management, which provides tools for authoring, maintaining, and administering sophisticated Web sites; and records management that enables control of the lifecycle of content objects by associating robust retention and disposition rules with each content as set. The company?s ECM solutions also provide email management services designed to enable the archiving, control, and monitoring of email; capture and delivery tools that provide the means of converting documents from analog sources; digital asset management; business process management services; content reporting tools for analyzing content and generating reports; and Open Text Everywhere that allows the Open Text ECM suite to be available via mobile devices. In addition, it offers industry specific solutions for government, technology/manufacturing, energy, financial services, pharmaceutical and life sciences, legal, and media sectors. Additionally, the company provides learning, consulting, hosting, and customer support and training services. It has strategic alliances with Microsoft Corporation, Oracle Corporation, and SAP AG. The company was founded in 1991 and is headquartered in Waterloo, Canada.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Shares of Open Text (NASDAQ: OTEX) got a boost, shooting up 12.23percent to $101.70 after the company reported upbeat Q2 results and announced a 2-for-1 stock split.

5 Best Diversified Bank Stocks To Watch Right Now: Furniture Brands International Inc. (FBN)

Furniture Brands International, Inc. engages in designing, manufacturing, sourcing, and retailing home furnishings in the United States and internationally. The company offers case goods, such as bedroom, dining room, and living room wood furniture; stationary upholstery products comprising sofas, loveseats, sectionals, and chairs; and motion upholstered furniture, including recliners and sleep sofas. It also provides occasional furniture, such as accent pieces, home entertainment centers, and home office furniture, as well as wood, metal, and glass tables; and decorative accessories and accent pieces. The company�s brand portfolio includes Thomasville, Broyhill, Lane, Drexel Heritage, Henredon, Pearson, Hickory Chair, Lane Venture, Maitland-Smith, La Barge, and Creative Interiors. It markets its products through its Thomasville retail stores, interior designers, multi-line/independent retailers, and mass merchant stores to retailers, including independently owned furnitu re stores, department stores, and chains. The company was formerly known as Interco Inc. and changed its name to Furniture Brands International, Inc. in 1996. Furniture Brands International, Inc. was founded in 1921 and is headquartered in St. Louis, Missouri.

Advisors' Opinion:
  • [By Sally Jones]

    Here�� a look at what goes inside those new homes: new furniture. As furniture makers increase outsourcing and the U.S. manufacturing sector declines, investors must be wondering about the future of American furniture companies. Trading histories show Guru billionaires have taken years of losses, especially in the case of Furniture Brand International Inc. (FBN), but the recent insider trades at Furniture Brand may be some indication of what we can expect from Guru shareholders when their second quarter trading activity in this sector is revealed.

  • [By FoxBusiness]

    In an interview to appear on FOX Business Network�� (FBN) Countdown to the Closing Bell (3PM/ET), Citigroup CEO Michael Corbat speaks with anchor Liz Claman about the company�� recovery. Corbat says, �� think when we look back, we've done a pretty monumental transformation of the company��and that ��e feel like we've got the right business model and the right mix of businesses.��Corbat also comments on cyber security saying, �� think the threat of cyber security is absolutely real��and that this is ��n area where we dedicate a lot of resources, people, hours, money, to making sure that we've got the best technology.��/p>

  • [By Fox Business News]

    Billionaire investor Carl Icahn spoke with FOX Business Network�� (FBN) Charlie Gasparino about his positions in Apple and Herbalife. He discussed his proposal for Apple to launch a $150 billion stock buyback, saying, ��hey could certainly innovate as much as they want and still do this buyback.��When asked whether he could maintain a stake in Herbalife for years, Icahn said, �� could. I have no compunction the way Herbalife is going right now.��Icahn also discussed his Twitter war with PIMCO Founder and Co-CIO Bill Gross, and said, �� certainly respect Bill Gross, but it�� a little fun.��/p>

  • [By Fox Business]

    Billionaire Investor Sam Zell spoke with FOX Business Network�� (FBN) Maria Bartiromo during Opening Bell with Maria Bartiromo in a wide ranging interview about the Federal Reserve, the stock market and growth sectors in the economy. Regarding the Federal Reserve, Zell said, �� just do not know whether the Fed has the guts to really complete the taper��and that the tapering won�� ��e over by October.��Zell discussed the stock market saying, �� think the stock market is over exuberant��and �� think that the stock market reflects the fact that there's very little other options��for investors. When asked about international investments Zell said, ��e have invested very little in Europe��and that ��exico is one of the places that we're very excited about.��Zell also commented on the commercial real estate market saying, the hot markets are ��an Francisco, New York and Seattle. Those three markets have pricing that's very different from the rest of the country.��/p>

Sunday, May 10, 2015

Best Biotech Stocks To Watch For 2014

Clinical stage biotechs are infamous for their volatile ways. Because these stocks trade more on news and rumors than fundamentals, they are often subject to the whims of emotional investors.

With that being said, developmental biotechs that fall hard on news could be worth taking a look at because they may have fallen for all the wrong reasons. Puma Biotechnology (NYSE: PBYI  ) , for example, plummeted by 25% about a month ago after reporting mid-stage clinical trial data for the company's flagship cancer drug PB272 (neratinib).

PBYI data by YCharts

Specifically, Puma reported data for PB272's ongoing trial at the American Society for Clinical Oncology's annual meeting for�its first cohort of 40 patients with metastatic breast cancer that has metastasized to the brain. What's key to understand is that 19 out of the 40 evaluable patients showed some form of response to the drug, but investors keyed in on the reports of severe diarrhea occurring in a number of patients.�

Top Valued Companies To Own In Right Now: Synergy Pharmaceuticals Inc (SGYP)

Synergy Pharmaceuticals, Inc., incorporated on February 11, 1992, is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company�� lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC). The Company�� active pharmaceutical ingredients (APIs) and the final formulated drug products are manufactured for it by third party contractors.

As of December 31, 2011, the Company was developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor. As of December 31, 2011, the Company was dosing patients in an 800-patient Phase II/III clinical trial of plecanatide to treat. It is also developing a second generation GC-C receptor analog, SP-333, which is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone.

The Company competes with Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.

Advisors' Opinion:
  • [By Monica Gerson]

    Breaking news

    Time Warner Cable (NYSE: TWC) reported a drop in its third-quarter profit. Time Warner Cable's quarterly profit fell to $532 million, or $1.84 per share, from $808 million, or $2.60 per share, in the year-ago period. To read the full news, click here. Synergy Pharmaceuticals (NASDAQ: SGYP) today announced the start of a phase 2 clinical trial to evaluate the safety and efficacy of SP-333, its second-generation GC-C agonist and once-daily oral treatment, in adult patients with opioid-induced constipation (OIC). To read the full news, click here. Cigna (NYSE: CI) reported a 19% rise in its third-quarter earnings and lifted its full-year earnings outlook. To read the full news, click here. Charm Communications (NASDAQ: CHRM) announced today that the special committee of the Company's board of directors, consisting of independent directors Mr. Zhan Wang, Mr. Andrew J. Rickards and Mr. Gang Chen, has retained China Renaissance Securities (Hong Kong) Limited as its financial advisor and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP as its legal advisor. To read the full news, click here.

    Posted-In: Bank of America US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Best Biotech Stocks To Watch For 2014: Cadus Corp (KDUS)

Cadus Corporation (Cadus), incorporated in January 23, 1992, has a wholly owned subsidiary, Cadus Technologies, Inc. (the Subsidiary), which holds all patents, patent applications, know how, licenses and drug discovery technologies of the Company. The Company maintains all its strains, as well as a biological database that catalogues its collection of cells, cell lines, yeast strains and genetic engineering tools. This database has approximately 30,000 entries, which include the phenotype and the genotype of the cell or yeast strain and its storage site. As of December 31, 2011, the Company had no internal or external drug discovery operations.

Yeast

The Company has developed technologies based on yeast that are useful in identifying drug discovery candidates targeted at G Protein-coupled receptors. Yeast is a single-celled microorganism that is used to make bread, beer and wine. Both yeast and human cells consist of a membrane, an intracellular region and a nucleus containing genes. The genes in yeast express proteins, including cell-surface receptors, such as G Protein-coupled receptors and signaling molecules, such as protein kinases, that are similar to human proteins.

Hybrid Yeast Cells

The Company developed a technology to insert human genes into yeast cells to create hybrid yeast cells. Its scientists created hybrid yeast cells by replacing yeast G Protein-coupled receptor genes and certain signaling molecules with their human equivalents. As a result, these hybrid yeast cells express a human G Protein-coupled receptor and a portion of its signaling pathway. These hybrid yeast cells can be used to identify those compounds that act as agonists or antagonists to that receptor or a molecule that is in its signaling pathway. The Company designed and developed more than 25 thousand genetically different yeast strains that can be used to build hybrid yeast cells (the Yeast System).

The Company competes with Glaxo Smith Kline, Plc.

Advisors' Opinion:
  • [By Geoff Gannon] cash producing business like ADDvantage (AEY) that happens to be overcapitalized. I'd much rather own a business with real earnings rather than wait for something to happen with a pile of cash.

    My question is this: How cheap is cheap enough? Clearly (to me), George Risk (RSKIA) is cheap at or even just above book value. It's a darn good business so I'm getting high quality assets and earnings power. That gets less clear when looking at lower quality businesses.

    For example:

    Solitron (SODI) sells at 74% of NCAV, has decent z- and f-scores, a FCF margin of 5.3% and an ROA of 12%.

Best Biotech Stocks To Watch For 2014: Puma Biotechnology Inc (PBYI)

Puma Biotechnology, Inc., incorporated in April 2007, is a development-stage biopharmaceutical company that acquires and develops products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. As of December 31, 2011, the Company licensed three drug candidates: PB272 (neratinib (oral)), which the Company is developing for the treatment of advanced breasts cancer patients and gastric cancer patients; PB272 (neratinib (intravenous)), which the Company is developing for the treatment of advanced cancer patients, and PB357.

PB272 (neratinib (oral))-Breast Cancer

Neratinib is a potent irreversible tyrosine kinase inhibitor, or TKI, that blocks signal transduction through the epidermal growth factor receptors (EGFRs), HER1, HER2 and HER4. The Company's initial focus is on the development of neratinib as an oral treatment of patients with HER2 positive metastatic breast cancer.

PB272 (neratinib (intravenous))

The Company develops neratinib as an intravenously administered agent. In pre-clinical studies the intravenous version of neratinib resulted in higher exposure levels of neratinib in pre-clinical models.

PB357

PB357 is an orally administered agent that is an irreversible TKI that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. PB357 is structurally similar to PB272. Pfizer completed single dose Phase I trials of PB357. The Company is evaluating PB357.

The Company competes with Genentech, GlaxoSmithKline, Roche, Boehringer Ingelheim, Takeda, Array Biopharma and Ambit Biosciences.

Advisors' Opinion:
  • [By John Udovich]

    Recent news surrounding small cap biotech stocks like�Xencor Inc (NASDAQ: XNCR), Prosensa Holding NV (NASDAQ: RNA),�Puma Biotechnology Inc (NYSE: PBYI),�Geron Corporation (NASDAQ: GERN)
    and TNI BioTech Inc (OTCQB: TNIB) show that while the sector and appetite for biotech�IPOs may have cooled, lottery tickets can still be found or occur in the sector. Just consider the following recent news or trends:

Best Biotech Stocks To Watch For 2014: Lpath Inc (LPTN)

Lpath, Inc. (Lpath), incorporated on September 18, 2002, is a biotechnology company focused on the discovery and development of bio-active lipid-targeted monoclonal antibody (mAb) therapeutics. The Company has three product candidates, iSONEP, ASONEP and Lpathomab. The Company's program, iSONEP, is a mAb against Sphingosine-1-Phosphate (S1P). As of December 31, 2012, it was in phase-II clinical trials for wet Age-Related Macular Degeneration. The Company is also advancing ASONEP, the systemic formulation of the mAb to S1P. ASONEP has completed a phase-I clinical trial and is entering phase-II clinical trials in Renal Cell Carcinoma.

Lpath's third product candidate, Lpathomab, is a mAb to the bioactive lipid, Lysophosphatidic Acid (LPA). The Company also applies its technology platform, ImmuneY2, to discovering mAbs to new bioactive lipid targets.

Advisors' Opinion:
  • [By Lauren Pollock]

    Lpath Inc.(LPTN) said it is no longer actively seeking to reacquire exclusive rights to its leading product candidate from Pfizer Inc.(PFE), saying the pharmaceutical giant informed the company that its offers weren’t competitive. The biotechnology company in October had warned that Pfizer might may divest itself of its exclusive option to co-develop the smaller firm’s leading product candidate–known as iSONEP.